Mr. Zhang has been with CBC since its founding, in January 2014, and most recently serving as a Managing Director and was responsible for the fund’s investments in pharmaceutical and biotech industry. During 2019-2023, he was an executive Director, Chief Operating Officer of Everest Medicines, a HK publicly listed biopharmaceutical company incubated by CBC. Prior to joining CBC Group, Mr. Zhang worked in various capacities in private equity and investment banking, including as a private equity investment officer at Capital International, Inc., a private equity arm of Capital Group, from March 2011 to February 2013, at Morgan Stanley Asia Limited, a subsidiary of Morgan Stanley (NYSE: MS), from May 2007 to March 2011 where his last position held was associate, and at BOCI Research Limited and BOCI Securities Limited from 2006 to 2007. Mr. Zhang received his bachelor’s degree in mathematics with honors from The University of Hong Kong in December 2006.